drugset / Trial / NCT02160262
Open-label Safety Study in Adults With ADHD
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the long-term safety and tolerability of SEP 225289 in adult subjects with Attention Deficit Hyperactivity Disorder (ADHD)
Timeline
- Start
- 2014-06
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dasotraline | Small molecule | 4 mg | — |
| Subject | Dasotraline | Small molecule | 6 mg | — |
| Subject | Dasotraline | Small molecule | 8 mg | — |